Ebola Vaccine
Showing 1 - 25 of 8,330
Ebola Virus Disease Trial in Decatur (Recombinant Vesicular Stomatitis Vaccine for Ebola (rVSV?G-ZEBOV-GP))
Not yet recruiting
- Ebola Virus Disease
- Recombinant Vesicular Stomatitis Vaccine for Ebola (rVSV∆G-ZEBOV-GP)
-
Decatur, GeorgiaThe Hope Clinic of the Emory Vaccine Center
Oct 20, 2023
Host Genetic Factors Underlying Ebola Virus Disease Risk,
Completed
- Ebola Virus Disease
-
Kalkata, Liberia
- +3 more
Aug 18, 2022
Healthy Trial in Cuangugu, Gysenyi, Kigali (Ad26.ZEBOV, MVA-BN-Filo)
Active, not recruiting
- Healthy
- Ad26.ZEBOV
- MVA-BN-Filo
-
Cuangugu, Rwanda
- +2 more
Jan 17, 2023
Ebola Virus Disease Trial in Kenema (rVSVDG-ZEBOV-GP Ebola Virus Vaccine (ERVEBO))
Not yet recruiting
- Ebola Virus Disease
- rVSVDG-ZEBOV-GP Ebola Virus Vaccine (ERVEBO)
-
Kenema, Eastern, Sierra LeoneKenema Government Hospital
Aug 7, 2023
Healthy Volunteers Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (rVSV-Zebov GP vaccine)
Active, not recruiting
- Healthy Volunteers
- rVSV-Zebov GP vaccine
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 7, 2023
Ebola Virus Trial in Kampala (cAd3-EBO S vaccine)
Completed
- Ebola Virus
- cAd3-EBO S vaccine
-
Kampala, UgandaMakerere University-Walter Reed Project
Nov 10, 2022
Ebola Virus Disease Trial in Goma, Kinshasa (Zabdeno® booster, Ervebo® booster)
Not yet recruiting
- Ebola Virus Disease
- Zabdeno® booster
- Ervebo® booster
-
Goma, Congo, The Democratic Republic of the
- +1 more
Nov 6, 2023
Ebola Vaccine Trial (ERVEBO® (rVSV?G-ZEBOV-GP))
Not yet recruiting
- Ebola Vaccine
- ERVEBO® (rVSV∆G-ZEBOV-GP)
- (no location specified)
Jul 17, 2023
Ebola Virus Disease Trial in Kinshasa (Ad26.ZEBOV, MVA-BN-Filo vaccine)
Active, not recruiting
- Ebola Virus Disease
- Ad26.ZEBOV, MVA-BN-Filo vaccine
-
Kinshasa, Congo, The Democratic Republic of theL'Institut National de Recherche Biomédicale RDC
Nov 15, 2021
Sudan Ebola Virus Vaccines Trial (CAd3, ChAdox1, rVSV-SUDV)
Not yet recruiting
- Sudan Ebola Virus Vaccines
- CAd3
- +3 more
- (no location specified)
Jun 8, 2023
Ebola Virus Disease Trial in Boende (Ad26.ZEBOV vaccine)
Completed
- Ebola Virus Disease
- Ad26.ZEBOV vaccine
-
Boende, Province De La Tshuapa, Congo, The Democratic Republic of theHôpital Général de Référence de Boende
Jan 3, 2023
Ebola Trial in Oxford (ChAdOx1 biEBOV)
Recruiting
- Ebola
- ChAdOx1 biEBOV
-
Oxford, United KingdomCentre for Clinical Vaccinology and Tropical Medicine, Churchill
Aug 10, 2022
Ebola Trial in Bagamoyo (ChAdOx1 biEBOV)
Recruiting
- Ebola
- ChAdOx1 biEBOV
-
Bagamoyo, TanzaniaBagamoyo Clinical Trial Facility
May 17, 2022
Vaccine-induced Immunity Against Ebola in Previously Vaccinated
Recruiting
- Immune Response
-
Goma, Congo, The Democratic Republic of the
- +1 more
May 18, 2022
Ebola Sudan Virus Disease Trial in Siaya, Kampala (cAD3-Sudan Ebolavirus Vaccine, Placebo)
Not yet recruiting
- Ebola Sudan Virus Disease
- cAD3-Sudan Ebolavirus Vaccine
- Placebo
-
Siaya, Kenya
- +1 more
Sep 7, 2023
Ebola Sudan Virus Disease Trial (rVSV?G-SEBOV-GP Vaccine or Placebo)
Not yet recruiting
- Ebola Sudan Virus Disease
- rVSV∆G-SEBOV-GP Vaccine or Placebo
- (no location specified)
Feb 10, 2023
Ebola Virus Disease Trial in N'Zerekore (ansuvimab, Ervebo)
Not yet recruiting
- Ebola Virus Disease
- ansuvimab
- Ervebo
-
N'Zerekore, GuineaCentre de Traitement Ebola de N'Zerekore
Oct 14, 2021
Ebola Virus Disease Trial in Lambarene (rVSV?G-ZEBOV-GP, V920)
Recruiting
- Ebola Virus Disease
- rVSVΔG-ZEBOV-GP, V920
-
Lambarene, Moyen-Ogooué, GabonCentre de Recherches Médicales de Lambaréné
Nov 18, 2021
Ebola Virus Disease Trial in Entebbe (Ad26.ZEBOV/MVA-BN-Filo)
Completed
- Ebola Virus Disease
-
Entebbe, UgandaMRC/UVRI & LSHTM Uganda Research Unit
May 10, 2021
Ebola Trial in Brisbane, Melbourne, Nedlands (Base Dose EBOV GP Vaccine, 2x Base Dose EBOV GP Vaccine, 4x Base Dose EBOV GP
Completed
- Ebola
- Base Dose EBOV GP Vaccine
- +5 more
-
Brisbane, Queensland, Australia
- +2 more
Nov 23, 2021
Ebola Disease, Immunisation Trial in Cincinnati (ChAd3-EBO-Z, MVA Multi-Filo Ebola Vaccine, Placebo)
Completed
- Ebola Disease
- Immunisation
- ChAd3-EBO-Z
- +2 more
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center - Infectious Disea
May 6, 2021
Ebola Virus Disease, Ebola, Hiv Trial in Nairobi, Masaka (Ad26.ZEBOV)
Active, not recruiting
- Ebola Virus Disease
- +2 more
- Ad26.ZEBOV
-
Nairobi, Kenya
- +1 more
Nov 26, 2021
Ebola Virus Disease Trial in Baltimore (HPIV3/?HNF/EbovZ GP vaccine, Placebo)
Suspended
- Ebola Virus Disease
- HPIV3/ΔHNF/EbovZ GP vaccine
- Placebo
-
Baltimore, Maryland
- +1 more
Mar 2, 2022
Ebola Disease, Marburg Disease Trial in Atlanta (Ad26 Zaire Ebola Vaccine, MVA Multi-Filo Ebola Vaccine)
Completed
- Ebola Disease
- Marburg Disease
- Ad26 Zaire Ebola Vaccine
- MVA Multi-Filo Ebola Vaccine
-
Atlanta, GeorgiaEmory Children's Center - Pediatric Infectious Diseases
Feb 18, 2021
Ebola Virus Disease Trial in Kambia (Ad26.ZEBOV booster vaccination, given at a dose of 5x10^10 vp, via IM injection)
Active, not recruiting
- Ebola Virus Disease
- Ad26.ZEBOV booster vaccination, given at a dose of 5x10^10 vp, via IM injection
-
Kambia, Sierra LeoneEBOVAC Kambia 1 clinic
Feb 25, 2022